Cambrex celebrated the grand opening of its new First Quarter Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, invitro diagnosis companies, hospitals and universities with analytical services for blood investigations and hemocompatibility testing. First Quarter Scientific's grand opening ceremony marked the formal inauguration of its new stability storage facility in Village-le-Bouillet, which spans over 2,000 square meters and is equipped with cutting-edge temperature-controlled storage chambers and monitoring and security systems. The event was attended by esteemed government officials, industry experts, and key stakeholders. This expansion into Belgium complements First Quarter Scientific's existing footprint in Waterford, Ireland, and is consistent with Cambrex's strategy to expand its portfolio of specialized solutions for pharmaceutical development and manufacturing across North America and Europe.